Clinical Trial

Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the efficacy of Losartan use post-operatively for reducing or preventing the development of arthrofibrosis and the associated adverse impacts on clinical outcomes.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-26; most recent amendment 2024-03-07.
Status change: Not Yet Recruiting → Recruiting 2023-11-04
Trial Details
NCT Number NCT06108063
Lead Sponsor Steadman Philippon Research Institute
Conditions Knee Arthroplasty, Total
Enrollment 120 participants
Start Date 2024-03-06
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-03-12